- Use of MLL/GRAF fusion mRNA for measurement of minimal residual disease during chemotherapy in an infant with acute monoblastic leukemia (AML-M5). Wilda, M., Perez, A.V., Bruch, J., Woessmann, W., Metzler, M., Fuchs, U., Borkhardt, A. Genes Chromosomes Cancer (2005)